Contact: Will Sansom
University of Texas Health Science Center at San Antonio
Caption: Veronica Galvan, Ph.D., of the Barshop Institute at the University of Texas Health Science Center at San Antonio, co-authored a PLoS ONE paper that showed rapamycin treatment prevented learning and memory deficits in mice engineered to develop Alzheimer's disease.
Credit: UT Health Science Center San Antonio
Usage Restrictions: None
Related news release: A drug that extends life span prevents Alzheimer's deficits